BIOLOGÍA CELULAR Y PATOLOGÍA
Departamento
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (3)
2023
-
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Current Medicinal Chemistry, Vol. 30, Núm. 16, pp. 1798-1812
-
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
International Journal of Molecular Sciences, Vol. 24, Núm. 21
2019
-
Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia
Leukemia, Vol. 33, Núm. 1, pp. 249-278